Cidofovir inhibits polyomavirus BK replication in human renal tubular cells downstream of viral early gene expression

American Journal of Transplantation

Volumn 8, Issue 7, 2008, Pages 1413-1422

  Bernhoff, E ^a,b   Gutteberg, T J ^a,b   Sandvik, K ^a   Hirsch, H H ^c,d   Rinaldo, C H ^a  

^a UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^b UNIVERSITY OF TROMSØ   (Norway)

^c UNIVERSITY OF BASEL   (Switzerland)

^d UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

BK nephropathy; BK polyoma virus; BK virus; BK virus allograft nephropathy; BK virus nephritis; Bone marrow transplantation; Cidofovir; Kidney allograft; Kidney transplantation; Proximal tubule; Real time polymerase chain reaction (PCR); Real time RT PCR

Indexed keywords

CIDOFOVIR; MESSENGER RNA; VIRUS DNA; VIRUS T ANTIGEN;

ARTICLE; CELL LEVEL; CONTROLLED STUDY; DNA REPLICATION; DOSE RESPONSE; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; KIDNEY TRANSPLANTATION; KIDNEY TUBULE CELL; POLYOMA VIRUS; PRIORITY JOURNAL; RECEPTOR BINDING; VIRUS GENE; VIRUS INFECTION; VIRUS LOAD; VIRUS REPLICATION;

ANTIVIRAL AGENTS; BK VIRUS; CELLS, CULTURED; CYTOSINE; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION, VIRAL; HUMANS; KIDNEY TUBULES, PROXIMAL; PHOSPHONIC ACIDS; VIRUS REPLICATION;

EID: 47249149259     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2008.02269.x     Document Type: Article

References (38)

1. Hirsch HH, Steiger J. Polyomavirus BK. Lancet Infect Dis 2003 3: 611 623.
2. Polo C, Perez JL, Mielnichuck A, Fedele CG, Niubo J, Tenorio A. Prevalence and patterns of polyomavirus urinary excretion in immunocompetent adults and children. Clin Microbiol Infect 2004 10: 640 644.
3. Randhawa PS, Finkelstein S, Scantlebury V et al. Human polyoma virus-associated interstitial nephritis in the allograft kidney. Transplantation 1999 67: 103 109.
4. Hirsch HH, Knowles W, Dickenmann M et al. Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients. N Engl J Med 2002 347: 488 496.
5. Ramos E, Drachenberg CB, Portocarrero M et al. BK virus nephropathy diagnosis and treatment: Experience at the University of Maryland Renal Transplant Program. Clin Transpl 2002 143 153.
6. Fishman JA. BK virus nephropathy-polyomavirus adding insult to injury. N Engl J Med 2002 347: 527 530.
7. Hirsch HH, Brennan DC, Drachenberg CB et al. Polyomavirus-associated nephropathy in renal transplantation: Interdisciplinary analyses and recommendations. Transplantation 2005 79: 1277 1286.
8. Rinaldo CH, Hirsch HH. Antivirals for the treatment of polyomavirus BK replication. Expert Rev Anti Infect Ther 2007 5: 105 115.
9. Benavides CA, Pollard VB, Mauiyyedi S, Podder H, Knight R, Kahan BD. BK virus-associated nephropathy in sirolimus-treated renal transplant patients: Incidence, course, and clinical outcomes. Transplantation 2007 84: 83 88.
10. Rajpoot DK, Gomez A, Tsang W, Shanberg A. Ureteric and urethral stenosis: A complication of BK virus infection in a pediatric renal transplant patient. Pediatr Transplant 2007 11: 433 435.
11. Cheerva AC, Raj A, Bertolone SJ, Bertolone K, Silverman CL. BK virus-associated hemorrhagic cystitis in pediatric cancer patients receiving high-dose cyclophosphamide. J Pediatr Hematol Oncol 2007 29: 617 621.
12. Andrei G, Fiten P, Goubau P et al. Dual infection with polyomavirus BK and acyclovir-resistant herpes simplex virus successfully treated with cidofovir in a bone marrow transplant recipient. Transpl Infect Dis 2007 9: 126 131.
13. De Clercq E. Acyclic nucleoside phosphonates: Past, present and future. Bridging chemistry to HIV, HBV, HCV, HPV, adeno-, herpes-, and poxvirus infections: The phosphonate bridge. Biochem Pharmacol 2007 73: 911 922.
14. Ho ES, Lin DC, Mendel DB, Cihlar T. Cytotoxicity of antiviral nucleotides adefovir and cidofovir is induced by the expression of human renal organic anion transporter 1. J Am Soc Nephrol 2000 11: 383 393.
15. Izzedine H, Launay-Vacher V, Deray G. Renal tubular transporters and antiviral drugs: An update. AIDS 2005 19: 455 462.
16. Ortiz A, Justo P, Sanz A et al. Tubular cell apoptosis and cidofovir-induced acute renal failure. Antivir Ther 2005 10: 185 190.
17. Cihlar T, Ho ES, Lin DC, Mulato AS. Human renal organic anion transporter 1 (hOAT1) and its role in the nephrotoxicity of antiviral nucleotide analogs. Nucleosides Nucleotides Nucleic Acids 2001 20: 641 648.
18. Miller DS. Nucleoside phosphonate interactions with multiple organic anion transporters in renal proximal tubule. J Pharmacol Exp Ther 2001 299: 567 574.
19. Wolf DL, Rodriguez CA, Mucci M, Ingrosso A, Duncan BA, Nickens DJ. Pharmacokinetics and renal effects of cidofovir with a reduced dose of probenecid in HIV-infected patients with cytomegalovirus retinitis. J Clin Pharmacol 2003 43: 43 51.
20. Farasati NA, Shapiro R, Vats A, Randhawa P. Effect of leflunomide and cidofovir on replication of BK virus in an in vitro culture system. Transplantation 2005 79: 116 118.
21. Leung AY, Chan MT, Yuen KY et al. Ciprofloxacin decreased polyoma BK virus load in patients who underwent allogeneic hematopoietic stem cell transplantation. Clin Infect Dis 2005 40: 528 537.
22. Magee WC, Aldern KA, Hostetler KY, Evans DH. Cidofovir and (S)-HPMPA are highly effective inhibitors of vaccinia virus DNA polymerase when incorporated into the template strand. Antimicrob Agents Chemother 2008 52: 586 597.
23. Ho HT, Woods KL, Bronson JJ, De BH, Martin JC, Hitchcock MJ. Intracellular metabolism of the antiherpes agent (S)-1-[3-hydroxy-2- (phosphonylmethoxy)propyl]cytosine. Mol Pharmacol 1992 41: 197 202.
24. Neyts J, Snoeck R, Schols D, Balzarini J, De Clercq E. Selective inhibition of human cytomegalovirus DNA synthesis by (S)-1-(3-hydroxy-2- phosphonylmethoxypropyl)cytosine [(S)-HPMPC] and 9-(1,3-dihydroxy-2- propoxymethyl)guanine (DHPG). Virology 1990 179: 41 50.
25. Grinde B, Gayorfar M, Rinaldo CH. Impact of a polyomavirus (BKV) infection on mRNA expression in human endothelial cells. Virus Res 2007 123: 86 94.
26. Hey AW, Johnsen JI, Johansen B, Traavik T. A two fusion partner system for raising antibodies against small immunogens expressed in bacteria. J Immunol Methods 1994 173: 149 156.
27. Leuenberger D, Andresen PA, Gosert R et al. Human Polyomavirus type 1 (BK virus) Agnoprotein is abundantly expressed, but immunologically ignored. Clin Vaccine Immunol 2007 14: 959 968.
28. Randhawa PS, Vats A, Zygmunt D et al. Quantitation of viral DNA in renal allograft tissue from patients with BK virus nephropathy. Transplantation 2002 74: 485 488.
29. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001 25: 402 408.
30. Randhawa P, Shapiro R, Vats A. Quantitation of DNA of polyomaviruses BK and JC in human kidneys. J Infect Dis 2005 192: 504 509.
31. Cole CN. Polyomavirinae: The viruses and their replication. In: Fields BN, Knipe DM, Howley PH, eds. Fields Virology. New York: Lippincott-Raven, 1996: 1997 2043.
32. Harris KF, Christensen JB, Imperiale MJ. BK virus large T antigen: Interactions with the retinoblastoma family of tumor suppressor proteins and effects on cellular growth control. J Virol 1996 70: 2378 2386.
33. Spanos WC, El-Deiry M, Lee JH. Cidofovir incorporation into human keratinocytes with episomal HPV 16 results in nonselective cytotoxicity. Ann Otol Rhinol Laryngol 2005 114: 840 846.
34. Kuypers DR, Vandooren AK, Lerut E et al. Adjuvant low-dose cidofovir therapy for BK polyomavirus interstitial nephritis in renal transplant recipients. Am J Transplant 2005 5: 1997 2004.
35. Cundy KC, Petty BG, Flaherty J et al. Clinical pharmacokinetics of cidofovir in human immunodeficiency virus-infected patients. Antimicrob Agents Chemother 1995 39: 1247 1252.
36. Hirsch HH, Gosert R, Funk GA. The 3rd International Transplant Infectious Disease Conference September 29-30, 2007, Prague, Czech Republic, Available from: http://www.intmedpress.com/tid/.
37. Funk GA, Steiger J, Hirsch HH. Rapid dynamics of polyomavirus type BK in renal transplant recipients. J Infect Dis 2006 193: 80 87.
38. Neyts J, De Clercq E. Efficacy of (S)-1-(3-hydroxy-2- phosphonylmethoxypropyl)cytosine for the treatment of lethal vaccinia virus infections in severe combined immune deficiency (SCID) mice. J Med Virol 1993 41: 242 246.